1998 (Cycle IV)
Innovative Awards: IDEA (Innovative, Developmental, and Exploratory Awards) Top
| The Role of a Newly Discovered Neuregulin in Breast Cancer | ||||
| Scripps Research Institute | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: IDEA | ||||
| Intracellular Signaling by PI3K in Breast Cancer Metastasis | ||||
| University of California, Davis | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: IDEA | ||||
Collaboration Awards: CRC (Community Research Collaboration) Full Research Awards Top
| Samoans and Breast Cancer: Evaluating a Theory-Based Program | ||||
| University of California, Irvine | ||||
| Research Priority: Health Policy & Health Services > Health Policy & Health Services | ||||
| Award Type: CRC Full | ||||
| Breast Cancer Risk Factors: Lesbian and Heterosexual Women | ||||
| Lyon-Martin Women's Health Services | ||||
| Research Priority: Etiology > Other searches for the causes | ||||
| Award Type: CRC Full | ||||
| Breast Cancer Risk Factors: Lesbian and Heterosexual Women | ||||
| University of California, San Francisco | ||||
| Research Priority: Etiology > Environment & gene/environment interactions | ||||
| Award Type: CRC Full | ||||
Collaboration Awards: TRC (Translational Research Collaboration) Pilot Awards Top
| Breast Tumor Markers and Response to Adjuvant Therapy | ||||
| Kaiser Foundation Research Institute | ||||
| Research Priority: Innovative Treatments > Gene therapy & other treatments | ||||
| Award Type: TRC Pilot | ||||
| Breast Cancer Markers and Response to Adjuvant Therapy | ||||
| Kaiser Foundation Research Institute | ||||
| Research Priority: Innovative Treatments > Gene therapy & other treatments | ||||
| Award Type: TRC Pilot | ||||
| Breast Tumor Markers and Response to Adjuvant Therapy | ||||
| Kaiser Foundation Research Institute | ||||
| Research Priority: Innovative Treatments > Gene therapy & other treatments | ||||
| Award Type: TRC Pilot | ||||
Career Development Awards: Postdoctoral Fellowship Top
| Cell Adhesion Signaling Defects in Breast Cancer | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Biochemical and Functional Characterization of BRCA1 | ||||
| Salk Institute for Biological Studies | ||||
| Research Priority: Pathogenesis > Mistakes on the master blueprint | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Siah-family Genes: Effectors of p53 in Breast Cancer | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Pathogenesis > Mistakes on the master blueprint | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Novel Binding Functions of Mutant p53 in Breast Cancer Cells | ||||
| Lawrence Berkeley National Laboratory | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Radiation, Reproductive & Menstrual Factors & Breast Cancer | ||||
| University of Southern California | ||||
| Research Priority: Etiology > Hormones & nutrition | ||||
| Award Type: Postdoctoral Fellowship | ||||
| A New System for Breast Cancer Drug Delivery | ||||
| California Pacific Medical Center Research Institute | ||||
| Research Priority: Innovative Treatments > New drug design | ||||
| Award Type: Postdoctoral Fellowship | ||||
Collaboration Awards: TRC (Translational Research Collaboration) Full Research Awards Top
| Timing of Breast Cancer Surgery, Menstrual Cycle & Prognosis | ||||
| University of California, San Diego | ||||
| Research Priority: Innovative Treatments > Gene therapy & other treatments | ||||
| Award Type: TRC Full | ||||
| Biologic Determinants of Response to Paclitaxel & Radiation | ||||
| University of Southern California | ||||
| Research Priority: Innovative Treatments > Hormone and chemotherapy targets | ||||
| Award Type: TRC Full | ||||
| Biological Determinants of Response to Paclitaxel and Radiat | ||||
| Molecular Medicine Research Institute | ||||
| Research Priority: Innovative Treatments > Hormone and chemotherapy targets | ||||
| Award Type: TRC Full | ||||
| Biological Determinants of Response to Paclitaxel and Radiat | ||||
| Molecular Medicine Research Institute | ||||
| Research Priority: Innovative Treatments > Hormone and chemotherapy targets | ||||
| Award Type: TRC Full | ||||
Innovative Awards: ITaMoCAs Top
| Novel Anti-vascular Agents for Breast Cancer Therapy | ||||
| SRI International | ||||
| Research Priority: Innovative Treatments > New drug design | ||||
| Award Type: ITaMoCAs | ||||
| Breast Cancer Immunotherapy Using CD4+ Lymphocytes | ||||
| University of California, San Diego | ||||
| Research Priority: Innovative Treatments > Immune therapy | ||||
| Award Type: ITaMoCAs | ||||
| Mechanism of Novel Anti-Angiogenic Therapy for Breast Cancer | ||||
| University of Southern California | ||||
| Research Priority: Innovative Treatments > New drug design | ||||
| Award Type: ITaMoCAs | ||||
| Molecular Mapping of Surgical Margins | ||||
| California Pacific Medical Center Research Institute | ||||
| Research Priority: Innovative Treatments > Gene therapy & other treatments | ||||
| Award Type: ITaMoCAs | ||||
| Reduced Breast Cancer Metastasis by Conjugated Linoleic Acid | ||||
| University of California, Davis | ||||
| Research Priority: Innovative Treatments > New drug design | ||||
| Award Type: ITaMoCAs | ||||
Career Development Awards: Training Program Top
| NCCC Breast Cancer Research Training Program | ||||
| University of Southern California | ||||
| Research Priority: Etiology > Environment & gene/environment interactions | ||||
| Award Type: Training Program | ||||
Collaboration Awards: CRC (Community Research Collaboration) Pilot Awards Top
| Marin County Breast Cancer Study of Adolescent Risk Factors | ||||
| University of California, San Francisco | ||||
| Research Priority: Etiology > Other searches for the causes | ||||
| Award Type: CRC Pilot | ||||
| Marin County Breast Cancer Study of Adolescent Risk Factors | ||||
| Marin Breast Cancer Watch | ||||
| Research Priority: Etiology > Other searches for the causes | ||||
| Award Type: CRC Pilot | ||||
Innovative Awards: IDEAS II Top
| Role of Rb Protein and Cell Cycle Defects in Breast Cancer | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: IDEAS II | ||||
| Targets of B Cell Infiltrate in Medullary Breast Cancer | ||||
| Scripps Research Institute | ||||
| Research Priority: Pathogenesis > Unraveling the path to breast cancer | ||||
| Award Type: IDEAS II | ||||
| Exercise and Risk of Breast Cancer Recurrence | ||||
| University of Southern California | ||||
| Research Priority: Etiology > Other searches for the causes | ||||
| Award Type: IDEAS II | ||||
| A Novel Drug Induces Apoptosis in Breast Cancer Cells | ||||
| Stanford University | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: IDEAS II | ||||
| Role of Gamma-catenin in a Breast Cancer Mouse Model | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: IDEAS II | ||||
| Chromatin Regulation of Breast Cancer Cell Senescence | ||||
| Lawrence Berkeley National Laboratory | ||||
| Research Priority: Pathogenesis > Searching the unknown | ||||
| Award Type: IDEAS II | ||||
| Genes Involved in Immortalization of Human Mammary Cells | ||||
| Lawrence Berkeley National Laboratory | ||||
| Research Priority: Pathogenesis > Unraveling the path to breast cancer | ||||
| Award Type: IDEAS II | ||||
| Progesterone Receptor and Remodeling of Basement Membrane | ||||
| Lawrence Berkeley National Laboratory | ||||
| Research Priority: Pathogenesis > Unraveling the path to breast cancer | ||||
| Award Type: IDEAS II | ||||
| Alteration of Developmental Genes in Breast Cancer | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Pathogenesis > Searching the unknown | ||||
| Award Type: IDEAS II | ||||
| Leukocyte Recruitment, Angiogenesis and Breast Cancer | ||||
| La Jolla Institute for Molecular Medicine | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: IDEAS II | ||||
| Epidemiology of Physical Activity and Ovarian Function | ||||
| Kaiser Foundation Research Institute | ||||
| Research Priority: Prevention & Risk Reduction > Active lifestyle modification | ||||
| Award Type: IDEAS II | ||||
Topic-targeted Research Awards: RFA (Request for Applications) Top
| A Novel Gene Associated With an Altered Risk of Breast Cance | ||||
| University of California, Berkeley | ||||
| Research Priority: Biology of the Normal Breast > Breast function | ||||
| Award Type: RFA | ||||
| Oral Contraceptives, Hormonal Risk Factors and BRCA1 | ||||
| University of Southern California | ||||
| Research Priority: Etiology > Environment & gene/environment interactions | ||||
| Award Type: RFA | ||||
| Hormonal Regulation of TGF Beta During Mammary Development | ||||
| Lawrence Berkeley National Laboratory | ||||
| Research Priority: Biology of the Normal Breast > Breast development | ||||
| Award Type: RFA | ||||
| Regulation of Breast Epithelial Cell Motility by Proteases | ||||
| Scripps Research Institute | ||||
| Research Priority: Biology of the Normal Breast > Breast function | ||||
| Award Type: RFA | ||||
Career Development Awards: New Investigator Top
| Antibody-IL-2 Fusion Protein for Breast Cancer Immunotherapy | ||||
| Sidney Kimmel Cancer Center | ||||
| Research Priority: Innovative Treatments > Immune therapy | ||||
| Award Type: New Investigator | ||||
| Dietary Indole Analogs for Breast Cancer Prevention | ||||
| SRI International | ||||
| Research Priority: Prevention & Risk Reduction > Other searches for the causes | ||||
| Award Type: New Investigator | ||||
| Understanding Breast Cancer Cell Metastasis to Bone | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: New Investigator | ||||
| Heregulin-specific Diphtheria Toxin as a Cancer Therapy | ||||
| Salk Institute for Biological Studies | ||||
| Research Priority: Innovative Treatments > New drug design | ||||
| Award Type: New Investigator | ||||
| Multi-ethnic Study of Genetic Control of Plasma Hormones | ||||
| University of Southern California | ||||
| Research Priority: Etiology > Hormones & nutrition | ||||
| Award Type: New Investigator | ||||
| TGF-Beta Receptor Signaling and Breast Cancer | ||||
| Lawrence Berkeley National Laboratory | ||||
| Research Priority: Pathogenesis > Unraveling the path to breast cancer | ||||
| Award Type: New Investigator | ||||
